Results 151 to 160 of about 30,918 (200)

Association between adenomyosis subtypes and concurrent endometrial lesions: a propensity score-matched retrospective study. [PDF]

Front Endocrinol (Lausanne)
Niu X, Wang Y, Zhai Y, Teng Y, Dong Z, Wang L.   +5 more
europepmc   +1 more source

The predictive diagnostic value of combined serum detection of CXCL12, VEGF, and CA125 for endometriosis. [PDF]

Medicine (Baltimore)
Xu H, Xie Z, Zheng Y, Wang C.
europepmc   +1 more source

Diagnostic value of serum biomarkers for identifying computed tomography abnormalities in male miners. [PDF]

Sci Rep
Huang Q, Lai L, Diao J, Chen L, Fang B.
europepmc   +1 more source

Associations of VEGF and CA125 with disease stage and pain among women with endometriosis: A cross-sectional study in Indonesia. [PDF]

Narra J
Sujudi A, Rusnaidi R, Dewi TP, Rajuddin R, Septivera Y.   +4 more
europepmc   +1 more source

Development and validation of a nomogram for predicting recurrence in epithelial ovarian cancer after primary cytoreductive surgery: A single-center retrospective study. [PDF]

Pak J Med Sci
Zhang W, Shu Y, Wan Z, Yang S.
europepmc   +1 more source

Flow orientation as a critical parameter in nanoscale membrane filtration for optimising small extracellular vesicle isolation. [PDF]

Nanoscale Adv
Nujhat S, Leese HS, Strickland MA, Di Lorenzo M, Moise S.   +4 more
europepmc   +1 more source

Development and validation of a nomogram integrating multi-dimensional clinical factors for predicting lung cancer-related mediastinal/hilar lymph node metastasis before endobronchial ultrasound-guided transbronchial needle aspiration. [PDF]

J Thorac Dis
Li K, Zhang H, Liang S, Wen W, Liu C, Zhang Y, Wang X, Deng J.   +7 more
europepmc   +1 more source

Circulating tumor cells with chromosome 8 aneuploidy are a diagnostic and prognostic monitoring biomarker for ovarian cancer. [PDF]

Chin J Cancer Res
Yang S, Li B, Cheng H, Ye X, Dou S, Wang Y, Song X, Yang H, Chang X, Li Y.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ovarian cancer: the duplicity of CA125 measurement

Nature Reviews Clinical Oncology, 2010
Since it was first described in 1981, CA125 has held an important role in monitoring patients with ovarian cancer. CA125 is elevated in 80% of patients with epithelial ovarian cancer at initial diagnosis and correlates well with response to therapy. CA125 monitoring is used for the follow up of patients with epithelial ovarian cancer, and elevations in
Karlan Beth Y
exaly   +3 more sources

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients

Gynecologic Oncology, 2007
Estrid V S Høgdall, Lise Christensen, Susanne K Kjaer   +2 more
exaly   +2 more sources